Watch Ticker

Sol-Gel Technologies Ltd. Ordinary Shares

Go to Sol-Gel Technologies Ltd. Ordinary Shares Website

$13.64

0.22 (1.64%)

Live

Previous Close

$13.42

Day Range

$13.28 - $13.8399

Previous Day Range

$12.5 - $13.43

Market Cap

$36.2 million USD

Day Vol.

8599

Previous Day Vol.

44880

Currency

USD

Primary Exchange

Nasdaq

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (P...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Sol-Gel Technologies Ltd. - Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Sol-Gel Technologies reported financial results for Q2 2024, including a net income of $1.9 million. The company provided updates on its pipeline, including the ongoing Phase 3 trial for SGT-610 in Gorlin Syndrome and the proof-of-concept study for SGT-210 in Darier disease. Sol-Gel also announced licensing agreements for its approved products TWYNEO and EPSOLAY in Europe and South Africa.

Related tickers: SLGL.

Read Full Article

Zacks Equity Research - Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates

SolGel Technologies (SLGL) delivered earnings and revenue surprises of -53.33% and 64.15%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Related tickers: SLGL, ACB.

Read Full Article

Trending Tickers

Please sign in to view